dc.contributor.author | Ocampo Sosa, Alain Antonio | |
dc.contributor.author | Guzmán Gómez, Laura P. | |
dc.contributor.author | Fernández Martínez, Marta | |
dc.contributor.author | Román, Elena | |
dc.contributor.author | Rodríguez Antona, Cristina | |
dc.contributor.author | Marco Reverté, Francesc | |
dc.contributor.author | Vila Estapé, Jordi | |
dc.contributor.author | Martínez Martínez, Luis | |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2015-11-05T11:46:24Z | |
dc.date.available | 2015-11-05T11:46:24Z | |
dc.date.issued | 2015-02 | |
dc.identifier.issn | 1098-6596 | |
dc.identifier.uri | http://hdl.handle.net/10902/7486 | |
dc.description.abstract | We describe here the occurrence of blaVIM-2 in 10 carbapenem-resistant Pseudomonas monteilii strains isolated from different clinical samples from patients at the University Hospital Marqués de Valdecilla in northern Spain. All the blaVIM-2-harboring P. monteilii isolates possessed a class 1 integron, with the cassette array [intI1_blaVIM-2_aac(6')-Ib_qacEΔ1_sul1]. Our results show the emergence of VIM-2-producing multidrug-resistant species other than Pseudomonas aeruginosa or Pseudomonas putida in a Spanish hospital. P. monteilii, although sporadically isolated, should also be considered an important metallo-β-lactamase (MBL) reservoir. | es_ES |
dc.format.extent | 3 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | American Society for Microbiology | es_ES |
dc.rights | © American Society for Microbiology | es_ES |
dc.source | Antimicrobial Agents and Chemotherapy. 2015 Feb;59(2):1334-6 | es_ES |
dc.title | Isolation of VIM-2-producing Pseudomonas monteilii clinical strains disseminated in a tertiary hospital in northern Spain | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.1128/AAC.04639-14 | |
dc.type.version | publishedVersion | es_ES |